PURCHASE AND SALE AGREEMENT dated as of December 20, 2022 between ATARA BIOTHERAPEUTICS, INC. and HCR Molag Fund, L.P.Purchase and Sale Agreement • February 8th, 2023 • Atara Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 8th, 2023 Company Industry JurisdictionThis PURCHASE AND SALE AGREEMENT (this “Purchase and Sale Agreement”), dated as of December 20, 2022 (the “Effective Date”), is entered into by and between Atara Biotherapeutics, Inc., a Delaware corporation (the “Seller”), and HCR Molag Fund, L.P., a Delaware limited partnership (the “Purchaser”).